Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OSEE interesting level II
OSEE- getting volume.
What I have thought about this new proposal is that it only
affects shell companies and anyone with a "valid" business
such as a juice kiosk can still "print" and sell shares and then file an S-8 a week later, won't hurt too many scammers.
PCOM might have a good day
Didn't get filled, they just FLIPped me off. Other wise
a great day..
LMRI is moving easily today.
EZEN on up
I like the looks of EZEN, but what do I know?
I like the red headed kid. BB yes the three divas are all
very good, maybe they should consolidate after
the series. The next Supremes?
OT I like the red headed kid the best because he's different, so out of place,like five generations behind, but I never thought he would get this far. My pick to win at the beginning of the final 12 was Jasmine Trias, but it seems the three other girls besides Diana are getting so much better every week and Jasmine is staying the same. My pick at this point would be Jennifer Hudson to win.
OT-The pen salesman was booted off, (the kid that
dances around a lot, Jon Lewis), Red the crooner and the little blonde girl were also in the bottom three.
Too bad WMNI didn't sign up William
Hung,would be $5.00 by now.
With that kind of news two weeks ago
NEOP would be 2 bucks by now.
NEOP news
DUBLIN, Ohio--(BUSINESS WIRE)--April 15, 2004--Neoprobe Corporation (OTCBB:NEOP - News), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced that notification was received from the United States Patent and Trademark Office regarding the issuance on Tuesday, April 13th of the second patent (U.S. Patent #6,719,698) covering the products of our subsidiary, Cardiosonix Ltd. (Cardiosonix). This second patent covers key aspects of the ADBF(TM) technology as well as innovations and enhancements to the Quantix® family of products for the measurement of blood flow in a variety of clinical applications that are also protected by U.S. Patent #6,503,205. Additional patents covering the Cardiosonix technology are pending in Europe.
PLKC - still trying to get rid of that 33m S-8
MBTT could get interesting.
TCPD- Nite has no shares
One single share. LOL
Ameritrade partially filled me with 1 (one) share of FATS
SKVY making a nice move, nite pushing
SKVY - in the sec. camera business, spread tightening
this morning.
ITCV ,ASNI, WCAP looking good, JLHY head fake?
BOCX halt sec link
http://www.otcbb.com/dynamic/marketwatch/mwsubhome.stm
ASNI- just 3,598,267 float, 22M OS,hardly any debt,
no lawsuits, no S-8's, doesn't appear to be any
insider selling, (none of the average POS traits).
Has a business plan of using infomercials to sell
their "intervention kits".
With the low float can't have very much actual resistance,
Looks as though profit taking today is making for a nice
entry price if your not in already.
Might be worth taking a look at.
(disclaimer I just bought in)
CYGX looks good today news yesterday in case you missed it
CytoGenix Inc. Anti-Sepsis Compound Works in Mice, Files US Patent Application
Tuesday April 6, 4:15 pm ET
HOUSTON--(BUSINESS WIRE)--April 6, 2004--CytoGenix Inc. (OTCBB:CYGX - News) announces the filing of a patent application with the US Patent and Trademark Office for an invention titled Oligodeoxynucleotide Intervention for Prevention and Treatment of Sepsis. This filing is a continuation of the ongoing program to protect this breakthrough technology.
Sepsis is a systemic inflammatory response to an infection primarily in the circulatory system. If untreated, it can lead to organ failure and death. The CDC reports that the incidence of sepsis has increased from 164,000 cases in 1979 to 660,000 cases in 2000. Sepsis is the 11th leading cause of death (9.3% of all deaths) in the United States.
The nation's annual cost associated with sepsis care is approximately $17 billion and the average length of hospital stay is 19.6 days per patient. The incidence of sepsis is likely to increase because of an aging population and the widespread use of broad-spectrum antibiotics that cause pathogens to mutate and become resistant.
Recent animal studies have shown that CytoGenix' gene silencing compound eliminates sepsis in mice. In several experiments, the control group of untreated infected animals died while those injected with the compound survived and flourished even after 14-days post-infection. These results are unequivocal and plans are underway to expand the animal studies to other species in preparation for submission of an Investigational New Drug application to the FDA later this year.
Dr. Malcolm Skolnick, CytoGenix President and CEO, commented, "These preclinical experiments have shown that this technology is highly effective in quickly reducing bacterial load in living animals. This is extremely important when fighting an infection that can cause death within hours in people who have suffered trauma, are post-operative or are immunocompromised.
"Another important feature of this technology is that it was designed to target genes that are absolutely essential to the existence of the organism. For this reason, the bacteria cannot become resistant by mutating this gene because any change will result in its death," adds Dr. Skolnick.
CytoGenix Inc. is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary ssDNA expression technology. CytoGenix currently has one issued US patent and 37 international or US pending patent applications claiming methods and materials in connection with this platform technology.
SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the Web site at www.cytogenix.com.
BUGS - IMO, scalping. NITE, FANC and SCHB will
take this to .11 before the day is done.
Added to the BUGS collection
Looks like BUGS are going to jump this month,jumped
a lot last year about this time. Yearly infestation?
BUGS-bid support looks good
BUGS are breeding
WWAT s up,
UCSY news
Universal Communication Systems, Inc. Enters Into a Major Joint Venture Agreement With Chinese Government Company to Establish AirWater and PV Solar Energy Operations in China
Thursday April 1, 8:51 am ET
Company Sets up Offices in Shanghai
MIAMI, April 1 /PRNewswire-FirstCall/ -- Universal Communication Systems, Inc. (OTC Bulletin Board: UCSY - News) company chairman Michael J. Zwebner announced today that the company has signed and entered into a major joint venture agreement with the General Manager of JiangSu Yangtze Petrochemical Co. Limited, of Shanghai, China, a division of PetroChina.
A new Chinese corporation, named Shanghai Gaochen Energy Technology and Development Co. Limited (SGETD), has been formed for the proposed new business.
Under the terms of the agreement, SGETD will initially market a range of AirWater machines and systems to the Chinese government and commercial markets. In addition, for UCSY subsidiary Millennium Electric T.O.U. Limited's PV Solar Energy Panels and Systems, the companies will jointly develop the local market for Photo Voltaic Solar Panels and Systems, for sales and distribution to both the Chinese market and for export to other markets around the world. It is also anticipated that the group will eventually contract to manufacture a range of Millennium's PV Solar panels in China.
In a statement made today, Michael Zwebner stated: "This agreement is the first step of our company operating in the huge and lucrative Chinese market. We are pleased to have joined up with this prestigious and powerful group. A detailed explanation detailing the full terms, as well as the implications of this agreement, will be announced soon."
About Universal Communication Systems Inc.
For further information, visit our web address: http://www.ucsy.com
About AirWater Corporation
For further information, visit our web address:
http://www.airwatercorp.com
About Millennium Electric T.O.U. Limited
Visit our web address: http://www.millennium-electric-inc.com
Safe Harbor Statement
Caution Concerning Forward-Looking Statements by Universal Communication Systems, Inc.
This document includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or beliefs, and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive, technological and/or regulatory factors, and factors affecting the integration of the businesses of Universal Communication Systems, Inc. More detailed information about these factors may be found in filings by Universal Communication Systems, Inc. with the Securities and Exchange Commission, including their most recent annual reports on Form 10-KSB and quarterly reports on Form 10-QSB. Universal Communication Systems, Inc. is under no obligation to, and expressly disclaims any such obligation to, update or alter their forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Universal Communication Systems, Inc., Miami
Rolando Sablon, 305-672-6344
Company web address: http://www.ucsy.com
For further information email us at: info@ucsy.com
IESV news
Intrepid Receives Significant Contract Extension
Wednesday March 31, 3:49 pm ET
IDAHO FALLS, Idaho, March 31, 2004 (PRIMEZONE) -- Intrepid Technology and Resources, Inc. (ITR), a renewable energy company (OTC BB:IESV.OB - News), has been awarded a significant contract extension to their ongoing Oak Ridge Associated Universities studies on the long-term effects of radiation at the United States National Laboratories. The contract extension is in excess of 400,000 dollars, which ITR believes is a strong indicator of the exceptional quality of work ITR produces and the high regard that present customers hold ITR in.
ITR would anticipate that their quantity of engineering services will decrease somewhat over the next couple of quarters as more staff are shifted to the construction, production and marketing of their alternate energy plants. At the present time and well into the foreseeable future the production and distribution of renewable energy represents a unique opportunity to the shareholders and employees of ITR.
It was announced on March 30, 2004 that the construction contract on ITR's flagship methane gas refinery was awarded and construction will begin within the week. That plant will be completed by late July and begin to produce commercial quantities of marketable gas by September. ITR sees their market in Idaho alone may exceed 50 million dollars in renewable energy revenues by 2010. Once the initial plant is operational the demand for ITR's technology and services may require ITR to add additional professional staff to service their growing alternate energy clientele and an increase in engineering services expected in 2005. Using 2004 as a base ITR should be able to double their alternate energy revenues for each of the next 5 years.
About Intrepid Technology: We are a premier technology application innovator of Biogas, bio-diesel and Ethanol products and services designed to assist in worldwide energy independence and reduce pollution (Green Energy). All of these are from renewable agriculture feedstock and industrial and agriculture waste materials.
Statements released by Intrepid Technologies and Resources that are not purely historical are forward-looking within the meaning of the ``Safe Harbor'' provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the company's business prospects and performance. The company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental and technological factors as discussed in the company's filings with the SEC on Forms 10-K, 10-Q and 8-K. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
Contact:
Intrepid Technology
Steve Ellis
(208) 529-5337
sellis@intrepid21.com
SOOTMAN- ED is a fellow who ran many of us through
his juice machine and squeezed the seeds out of us
whith his "extra dillution", and of course the news
of additional shares were not published or reported to
the SEC until after the promotion began. CLSI on the
other hand looks like a real company with honorable
intentions.
CLSI- no ED's there. The Company anticipates using its working capital to fund ongoing operations, including general and administrative expenses, equipment purchases, equipment manufacturing, travel, marketing and research and development. The Company anticipates having sufficient working capital to fund operations for the fiscal year ending September 30, 2004.
number of shares outstanding 365,118,000
(float approx. 208m)
ABCI Not surprised there is no volume, still no fill after
10 min..
ABCI- shell, the next ATEG?
NNOS could be a bargain this morning
looks like the shareholders got the GFYF food treatment.
TSBB- selling into 25 press unrealeses so far this year
has created a lot of stuck holders. Unless something
substantial materializes before the June CD's kick in, this thing will find it's last home before BR in the subpenny house. Sorry, JMO
PVSS- most of the long term owners and stuckholders are gone, one more good press release and it will go.